ACHC FRAUD NOTICE: BFA Law Alerts Acadia Healthcare Investors of the December 16 Securities Fraud Deadline – Contact the Firm if You Incurred Losses (NASDAQ:ACHC)

Core Viewpoint - A lawsuit has been filed against Acadia Healthcare Company, Inc. and certain senior executives, alleging misrepresentation of financial results related to insurance fraud and improper patient detainment practices [1][2][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until December 16, 2024, to request to lead the case [2]. Group 2: Allegations Against Acadia - Acadia is one of the largest for-profit psychiatric hospital chains in the U.S., and the complaint alleges that the company misrepresented its financial results due to insurance fraud and holding patients against their will when not medically necessary [3]. - A New York Times investigation highlighted that Acadia's success was partly due to luring patients and detaining them unnecessarily, leading to a stock price drop of $3.72 per share (4.5$75.66 to $63.28 per share [5]. - An October 18, 2024, New York Times article reported that the Veterans Affairs Department is investigating Acadia for potential insurance fraud, causing a further 12$59.32 to $52.03 per share [6].